Status:
ACTIVE_NOT_RECRUITING
CaroRite™ for Skin Health and Signs of Ageing
Lead Sponsor:
RDC Clinical Pty Ltd
Collaborating Sponsors:
Bio-Gen Extracts Pvt. Ltd.
Conditions:
Healthy Volunteer
Skin Condition
Eligibility:
FEMALE
40-55 years
Phase:
PHASE4
Brief Summary
The goal of this study is to investigate the efficacy of carotenoids administered orally on skin health, skin condition and visible signs of ageing in healthy females aged 40-55 years old. Researcher...
Eligibility Criteria
Inclusion
- Females 40-55 years (inclusive)
- Generally healthy
- BMI 18.5-29.9 kg/m2 (inclusive)
- Able to provide informed consent
- Agree not to change regular skincare routine
- Agree to not participate in another clinical trial while enrolled in this trial
- Agree to not significantly change current diet and/or exercise frequency or intensity during study period
Exclusion
- Regularly taking carotenoid containing medication/supplements within the previous 2 months
- Have a serious illness e.g. mood disorders such as clinical depression, anxiety disorder or bipolar disorder, neurological disorders such as MS, kidney disease, liver disease or heart conditions
- Have an unstable illness e.g. diabetes and thyroid gland dysfunction
- Current malignancy (excluding Basal Cell Carcinoma) or chemotherapy or radiotherapy treatment for malignancy within the previous 2 years
- Received cosmetic surgery or procedures, including Botox and other injectables, microdermabrasion and laser treatments on their face within last 3 months prior to enrolment and agree not to have these treatments during the study period.
- Medications for acne or other skin conditions including topical retinoids (Rein-A, Retrieve) oral retinoids such as Isotretinoin (Roaccutane), benzoyl peroxide, AHA's, serum, chemical peels within 1 month prior to screening.
- Currently taking carotenoid supplements (Beta-Carotene, Lycopene, Lutein, Zeaxanthin, Astazanthin)
- Active smokers, nicotine use or drug (prescription or illegal substances) abuse
- Chronic past and/or current alcohol use (\>14 alcoholic drinks week)
- Pregnant or lactating women
- Allergic to any of the ingredients in active or placebo formula
- Participants who are currently participating in any other clinical trial or who have participated in a clinical trial that may affect skin health during the past 1 month
- Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion
Key Trial Info
Start Date :
July 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06878001
Start Date
July 7 2025
End Date
December 1 2025
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RDC Clinical
Brisbane, Queensland, Australia, 4006